The clubbers' drug is now being studied as a treatment for anxiety and post-traumatic stress disorder. Erika Check charts its rocky road from the psychedelic underground to the psychiatric clinic.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Abraham, H. D., Aldridge, A. M. & Gogia, P. Neuropsychopharmacology 14, 285–298 (1996).
Greer, G. & Tolbert, R. J. Psychoactive Drugs 18, 319–327 (1986).
Ricaurte, G., Bryan, G., Strauss, L., Seiden, L. & Schuster, C. Science 229, 986–988 (1985).
Ricaurte, G. A., DeLanney, L. E., Irwin, I. & Langston, J. W. Brain Res. 446, 165–168 (1988).
Ricaurte, G. A. et al. J. Am. Med. Assoc. 260, 51–55 (1988).
Ricaurte, G. A., DeLanney, L. E., Wiener, S. G., Irwin, I. & Langston, J. W. Brain Res. 474, 359–363 (1988).
Green, A. R., Mechan, A. O., Elliott, J. M., O'Shea, E. & Colado, M. I. Pharmacol. Rev. 55, 463–508 (2003).
McCann, U. D., Ridenour, A., Shaham, Y. & Ricaurte, G. A. Neuropsychopharmacology 10, 129–138 (1994).
McCann, U. D., Szabo, Z., Scheffel, U., Dannals, R. F. & Ricaurte, G. A. Lancet 352, 1433–1437 (1998).
Allen, R. P., McCann, U. D. & Ricaurte, G. A. Sleep 16, 560–564 (1993).
Montoya, A. G., Sorrentino, R., Lukas, S. E. & Price, B. H. Harv. Rev. Psychiatry 10, 212–220 (2002).
Morgan, M. J. Psychopharmacology 152, 230–248 (2000).
Vollenweider, F. X., Gamma, A., Liechti, M. & Huber, T. Neuropsychopharmacology 19, 241–251 (1998).
McCann, U. D. & Ricaurte, G. A. Neuropsychopharmacology 24, 333–336 (2001).
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J. & McCann, U. D. Science 297, 2260–2263 (2002).
Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J. & McCann, U. D. Science 301, 1479 (2003).
Grob, C. S., Poland, R. E., Chang, L. & Ernst, T. Behav. Brain Res. 73, 103–107 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Check, E. The ups and downs of ecstasy. Nature 429, 126–128 (2004). https://doi.org/10.1038/429126a
Issue date:
DOI: https://doi.org/10.1038/429126a
This article is cited by
-
Rhynchophylline down-regulates NR2B expression in cortex and hippocampal CA1 area of amphetamine-induced conditioned place preference rat
Archives of Pharmacal Research (2010)
-
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Molecular Neurobiology (2009)
-
Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats
BMC Neuroscience (2008)
-
MDMA Induces EPSP–Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT4 and β1 Receptors
Neuropsychopharmacology (2008)
-
A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users
Neuropsychopharmacology (2007)
